논문 목록
2건-
Understanding the Factors Related to Early Discontinuation of Lutetium-177 Vipivotide Treatment in Men With Metastatic Castration-Resistant Prostate Cancer at a Single Institution.
Background Lutetium-177 vipivotide tetraxetan (Lu-177 vipivotide) is a radiopharmaceutical treatment for metastatic castration-resistant prostate cancer (mCRPC). Understanding the factors that hinder treatment completion with Lu-177 vipivot…
- Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A.